{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:54:54Z","timestamp":1792439694206,"version":"4.5.0"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["North Am J Med Sci"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/1947-2714.103310","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T01:25:10Z","timestamp":1352424310000},"page":"523","source":"Crossref","is-referenced-by-count":175,"title":["Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases"],"prefix":"10.4103","volume":"4","author":[{"given":"Mahdi","family":"Garelnabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Litvinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halleh","family":"Mahini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1947-2714.103310-1","doi-asserted-by":"crossref","unstructured":"Primo-Parmo SL, Sorenson RC, Teiber JF, La Du BN, The human serum paraoxonase\/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996;33:498-507.","DOI":"10.1006\/geno.1996.0225"},{"key":"key-10.4103\/1947-2714.103310-2","first-page":"412","volume-title":"Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes","author":"Harel","year":"2004","journal-title":"Nat Struct Mol Biol"},{"key":"key-10.4103\/1947-2714.103310-3","first-page":"1239","volume-title":"Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities","author":"Draganov","year":"2005","journal-title":"J Lipid Res"},{"key":"key-10.4103\/1947-2714.103310-4","first-page":"6371","volume-title":"Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase","author":"Khersonsky","year":"2005","journal-title":"Biochemistry"},{"key":"key-10.4103\/1947-2714.103310-5","first-page":"821","volume-title":"Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease","author":"Kerkeni","year":"2006","journal-title":"Clin Biochem"},{"key":"key-10.4103\/1947-2714.103310-6","first-page":"915","volume-title":"Beyond cholesterol.Modifications of low-density lipoprotein that increase its atherogenicity","author":"Steinberg","year":"1989","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1947-2714.103310-7","first-page":"275","volume-title":"High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein","author":"Parthasarathy","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/1947-2714.103310-8","first-page":"152","volume-title":"Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein","author":"Mackness","year":"1991","journal-title":"FEBS Lett"},{"key":"key-10.4103\/1947-2714.103310-9","first-page":"1581","volume-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions.A possible peroxidative role for paraoxonase","author":"Aviram","year":"1998","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1947-2714.103310-10","first-page":"129","volume-title":"Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase","author":"Mackness","year":"1993","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1947-2714.103310-11","first-page":"2882","volume-title":"Protective effect of high density lipoprotein associated paraoxonase.Inhibition of the biological activity of minimally oxidized low density lipoprotein","author":"Watson","year":"1995","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1947-2714.103310-12","first-page":"2260","volume-title":"Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH","author":"Teiber","year":"2004","journal-title":"J Lipid Res"},{"key":"key-10.4103\/1947-2714.103310-13","first-page":"284","volume-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"key-10.4103\/1947-2714.103310-14","first-page":"9","volume-title":"Paraoxonase 1 (PON1) attenuates macrophage oxidative status: Studies in PON1 transfected cells and in PON1 transgenic mice","author":"Rozenberg","year":"2005","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1947-2714.103310-15","first-page":"10141","volume-title":"Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence","author":"Hassett","year":"1991","journal-title":"Biochemistry"},{"key":"key-10.4103\/1947-2714.103310-16","first-page":"480","volume-title":"Human tissue distribution of paraoxonases 1 and 2 mRNA","author":"Mackness","year":"2010","journal-title":"IUBMB Life"},{"key":"key-10.4103\/1947-2714.103310-17","first-page":"336","volume-title":"Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: Selective secretion of PON1 and PON2","author":"Shamir","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"key-10.4103\/1947-2714.103310-18","first-page":"77","volume-title":"Polymorphisms in the human paraoxonase (PON1) promoter","author":"Brophy","year":"2001","journal-title":"Pharmacogenetics"},{"key":"key-10.4103\/1947-2714.103310-19","first-page":"1725","volume-title":"High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes","author":"Ikeda","year":"2008","journal-title":"Metabolism"},{"key":"key-10.4103\/1947-2714.103310-20","first-page":"279","volume-title":"Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells","author":"Osaki","year":"2004","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1947-2714.103310-21","first-page":"142","volume-title":"Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene","author":"Ota","year":"2005","journal-title":"Metabolism"},{"key":"key-10.4103\/1947-2714.103310-22","first-page":"439","volume-title":"Pitavastatin induces PON1 expression through p44 \/ 42 mitogen-activated protein kinase signaling cascade in Huh7 cells","author":"Arii","year":"2009","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1947-2714.103310-23","first-page":"2083","volume-title":"Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: A role for sterol regulatory element-binding protein-2","author":"Deakin","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/1947-2714.103310-24","first-page":"5209","volume-title":"Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism","author":"Gou\u00e9dard","year":"2004","journal-title":"Mol Cell Biol"},{"key":"key-10.4103\/1947-2714.103310-25","first-page":"2142","volume-title":"Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin","author":"Jaichander","year":"2008","journal-title":"J Lipid Res"},{"key":"key-10.4103\/1947-2714.103310-26","first-page":"2378","volume-title":"Induction of the paraoxonase-1 gene expression by resveratrol","author":"Gou\u00e9dard","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/1947-2714.103310-27","first-page":"519","volume-title":"Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells","author":"Cheng","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/1947-2714.103310-28","first-page":"301","volume-title":"Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4","author":"Gutierrez","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/1947-2714.103310-29","first-page":"384","volume-title":"A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids","author":"Shih","year":"2006","journal-title":"J Lipid Res"},{"key":"key-10.4103\/1947-2714.103310-30","first-page":"61","volume-title":"Human liver paraoxonase (PON1): Subcellular distribution and characterization","author":"Gonzalvo","year":"1998","journal-title":"J Biochem Mol Toxicol"},{"key":"key-10.4103\/1947-2714.103310-31","first-page":"4301","volume-title":"Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism","author":"Deakin","year":"2002","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1947-2714.103310-32","first-page":"17","volume-title":"Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells","author":"Deakin","year":"2005","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1947-2714.103310-33","first-page":"2214","volume-title":"Human serum Paraoxonase\/Arylesterase\u2032s retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: Apolipoprotein A-I stabilizes activity","author":"Sorenson","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/1947-2714.103310-34","first-page":"762","volume-title":"Protein composition determines the anti-atherogenic properties of HDL in transgenic mice","author":"Schultz","year":"1993","journal-title":"Nature"},{"key":"key-10.4103\/1947-2714.103310-35","first-page":"11843","volume-title":"High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I","author":"Gaidukov","year":"2005","journal-title":"Biochemistry"},{"key":"key-10.4103\/1947-2714.103310-36","first-page":"532","volume-title":"ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I","author":"Gaidukov","year":"2010","journal-title":"Biochemistry"},{"key":"key-10.4103\/1947-2714.103310-37","first-page":"395","volume-title":"Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency","author":"Noto","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/1947-2714.103310-38","first-page":"789","volume-title":"Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: A new mechanism linking HDL protein composition and antiatherogenic potential","author":"Ribas","year":"2004","journal-title":"Circ Res"},{"key":"key-10.4103\/1947-2714.103310-39","first-page":"457","volume-title":"Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: Evidence of a potentially relevant species-specific interaction with diet","author":"Escol\u00e0-Gil","year":"1998","journal-title":"J Lipid Res"},{"key":"key-10.4103\/1947-2714.103310-40","first-page":"102","volume-title":"HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress","author":"Deakin","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"key-10.4103\/1947-2714.103310-41","first-page":"55","volume-title":"Paraoxonase 1 (PON1) is present in postprandial chylomicrons","author":"Fuhrman","year":"2005","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1947-2714.103310-42","first-page":"123","volume-title":"Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue.Implications for its physiological role","author":"Rodrigo","year":"2001","journal-title":"Chem Biol Interact"},{"key":"key-10.4103\/1947-2714.103310-43","first-page":"146","volume-title":"Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues","author":"Marsillach","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"key-10.4103\/1947-2714.103310-44","first-page":"1233","volume-title":"Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis","author":"Mackness","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/1947-2714.103310-45","first-page":"308","volume-title":"Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques","author":"Marsillach","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"key-10.4103\/1947-2714.103310-46","first-page":"1630","volume-title":"Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model","author":"Shih","year":"1996","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1947-2714.103310-47","first-page":"17527","volume-title":"Combined serum paraoxonase knockout\/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis","author":"Shih","year":"2000","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1947-2714.103310-48","first-page":"226","volume-title":"Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia","author":"Ng","year":"2008","journal-title":"Cardiovasc Pathol"},{"key":"key-10.4103\/1947-2714.103310-49","first-page":"921","volume-title":"Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins","author":"Oda","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/1947-2714.103310-50","first-page":"484","volume-title":"Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice","author":"Tward","year":"2002","journal-title":"Circulation"},{"key":"key-10.4103\/1947-2714.103310-51","first-page":"1545","volume-title":"Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome","author":"Mackness","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/1947-2714.103310-52","first-page":"508","volume-title":"Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis","author":"Guns","year":"2008","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/1947-2714.103310-53","first-page":"975","volume-title":"Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk","author":"Wang","year":"2012","journal-title":"DNA Cell Biol"},{"key":"key-10.4103\/1947-2714.103310-54","first-page":"141","volume-title":"Association between PON1 activity and coronary heart disease risk: A meta-analysis based on 43 studies","author":"Zhao","year":"2012","journal-title":"Mol Genet Metab"},{"key":"key-10.4103\/1947-2714.103310-55","first-page":"490","volume-title":"Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population","author":"Wang","year":"2010","journal-title":"J Hum Genet"},{"key":"key-10.4103\/1947-2714.103310-56","first-page":"901","volume-title":"Serum paraoxonase 1 activity predicts arterial stiffness in renal transplant recipients","author":"Gungor","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"key-10.4103\/1947-2714.103310-57","first-page":"e17805","volume-title":"Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis","author":"Gupta","year":"2011","journal-title":"PLoS One"},{"key":"key-10.4103\/1947-2714.103310-58","first-page":"88","volume-title":"Serum paraoxonase-1 (PON1) activities (PONase\/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population","author":"Gupta","year":"2011","journal-title":"Gene"},{"key":"key-10.4103\/1947-2714.103310-59","first-page":"867","volume-title":"Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South","author":"Coombes","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"key-10.4103\/1947-2714.103310-60","first-page":"681","volume-title":"Paraoxonase 1 polymorphisms as the risk factor of coronary heart disease in a Thai population","author":"Likidlilid","year":"2010","journal-title":"Acta Cardiol"},{"key":"key-10.4103\/1947-2714.103310-61","first-page":"141","volume-title":"Paraoxonase 1 polymorphism Q192R affects the pro-inflammatory cytokine TNF-alpha in healthy males","author":"L\u00fcersen","year":"2011","journal-title":"BMC Res Notes"},{"key":"key-10.4103\/1947-2714.103310-62","first-page":"1428","volume-title":"Effects of 5\u2032 regulatory-region polymorphisms on paraoxonase-gene (PON1) expression","author":"Brophy","year":"2001","journal-title":"Am J Hum Genet"},{"key":"key-10.4103\/1947-2714.103310-63","first-page":"2935","volume-title":"Two alleles of the human paraoxonase gene produce different amounts of mRNA.An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism","author":"Leviev","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key-10.4103\/1947-2714.103310-64","first-page":"265","volume-title":"Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon","author":"Mackness","year":"1997","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/1947-2714.103310-65","doi-asserted-by":"crossref","unstructured":"Richter RJ, Jampsa RL, Jarvik GP, Costa LG, Furlong CE. Determination of paraoxonase 1 status and genotypes at specific polymorphic sites. Curr Protoc Toxicol 2004; Chapter 4:Unit 4.12.","DOI":"10.1002\/0471140856.tx0412s19"},{"key":"key-10.4103\/1947-2714.103310-66","first-page":"49","volume-title":"Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes","author":"Bayrak","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"key-10.4103\/1947-2714.103310-67","first-page":"57","volume-title":"Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification","author":"Mackness","year":"1998","journal-title":"FEBS Lett"},{"key":"key-10.4103\/1947-2714.103310-68","first-page":"606","volume-title":"Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis","author":"Dahabreh","year":"2010","journal-title":"Genet Med"},{"key":"key-10.4103\/1947-2714.103310-69","first-page":"449","volume-title":"Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: A meta-analysis","author":"Banerjee","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"key-10.4103\/1947-2714.103310-70","first-page":"377","volume-title":"Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: A meta-analysis based on 88 case-control studies","author":"Wang","year":"2011","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/1947-2714.103310-71","first-page":"17","volume-title":"The association of the PON1 Q192R polymorphism with coronary heart disease: Findings from the British Women\u2032s Heart and Health cohort study and a meta-analysis","author":"Lawlor","year":"2004","journal-title":"BMC Genet"},{"key":"key-10.4103\/1947-2714.103310-72","first-page":"689","volume-title":"Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: Meta-analysis of 43 studies","author":"Wheeler","year":"2004","journal-title":"Lancet"}],"container-title":["North American Journal of Medical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T08:23:01Z","timestamp":1562314981000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.najms.org\/text.asp?2012\/4\/11\/523\/103310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"alternative-id":["103310"],"URL":"https:\/\/doi.org\/10.4103\/1947-2714.103310","relation":{},"ISSN":["1947-2714"],"issn-type":[{"value":"1947-2714","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}